Mean annual total healthcare costs (€) of patients with IBD with infliximab (Remicade and Inflectra included) treatment compared with patients with IBD without infliximab treatment in a tertiary-level clinic
| Infliximab (n=197) | No infliximab (n=2011) | |
| Infliximab | 6880 (4999) | 0 |
| Outpatient clinic | 1795 (1034) | 942* (1241) |
| Hospitalisation | 629 (1837) | 509 (2083) |
| Surgery | 1378 (3754) | 478* (2169) |
| Emergency department | 335 (826) | 325 (1223) |
| Imaging | 186 (308) | 172 (315) |
| Laboratory | 694 (472) | 301* (760) |
| Diagnostic procedures | 803 (1893) | 782 (1955) |
| Total costs | 12 563 (7366) | 3406* (7082) |
SD presented in parentheses.
*P<0.001, otherwise no statistically significant difference.
IBD, inflammatory bowel disease.